Genespire patched together a €46.6 million (about $52 million) funding round to get its lead gene therapy into the clinic in ...

Wave Life Sciences said new Phase 2 biomarker data for its exon-skipping therapy are promising for certain patients with ...

Sen. Bernie Sanders (I-VT) told Novo Nordisk CEO Lars Fruergaard Jørgensen that three major pharmacy benefit managers have ...

Regeneron’s stock $REGN dipped about 4% on Tuesday following a loss in its legal battle with Amgen over competitors to its ...

The FDA's Oncologic Drugs Advisory Committee will meet Thursday to discuss whether several immune checkpoint inhibitor drugs ...

Biotech company SIGA Technologies has fired Chief Medical Officer Jay Varma, days after the publication of secret recordings ...

Biomedicines announced another pharma partnership Tuesday, agreeing to work on several protein therapies with the Swiss ...

Sanofi has appointed Mike Quigley, a former executive at Gilead and Bristol Myers Squibb, as the French pharma's next chief ...

PCI Pharma Services is pouring $365 million to expand its US and Irish footprint for commercial and clinical packaging of ...

Biotech investment firm Samsara BioCapital has added three new venture partners in recent months to expand its network, ...

You win some, you lose some — that’s the risk of trying to predict the next hot biotechs. Since 2018, the Endpoints 11 awards ...

Amgen released data from two pivotal trials on Tuesday that showed its experimental drug rocatinlimab succeeded in a Phase 3 ...